March 2022 Presentation
ACS National Meeting
Optimization of indole-based antagonists of toll-like receptors 7 and 8 (TLR7/8)
March 2022 Poster
ASCPT
BMS-986256, An Oral Novel Toll-like Receptor 7 and 8 (TLR7/8) Inhibitor, Is Not A Sensitive Substrate of Cytochrome P450 3A4: Clinical Evaluation with Itraconazole
March 2022 Poster
ACS National Meeting
Structure-based design of 2-(pyridin-2(1H)-one)indoles as antagonists of the toll-like receptors TLR7 and TLR8 for the treatment of autoimmune diseases
November 2021 Poster
ACR Convergence
First-in-Human Safety, Pharmacokinetic and Pharmacodynamic Study of Escalating Single- and Multiple-Doses of BMS-986256, a Novel, Potent, Oral Inhibitor of TLR7 and TLR8
November 2021 Presentation
ACR Convergence
Inhibition of Toll-Like Receptor 7 (TLR7) with the Potent and Selective Inhibitor of Human TLR7 and TLR8 BMS-986256 Provides Robust Efficacy in Murine Lupus Models, Reversing Established Disease
November 2021 Poster
ACR Convergence